TickerFactsScreenerDevelopers

Theravance Biopharma, Inc. (TBPH) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $02013: $02014: $89.22M2015: $112.71M2016: $344.71M2017: $88.98M2018: $378.02M2019: $58.06M2020: $81.47M2021: $89.96M2022: $298.17M2023: $39.55M2024: $37.80M2025: $167.81M$167.81M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$167.81M+344.0%
2024$37.80M-4.4%
2023$39.55M-86.7%
2022$298.17M+231.5%
2021$89.96M+10.4%
2020$81.47M+40.3%
2019$58.06M-84.6%
2018$378.02M+324.8%
2017$88.98M-74.2%
2016$344.71M+205.8%
2015$112.71M+26.3%
2014$89.22M—
2013$0—
2012$0—